In conclusion, this study is the first to prove that FOXQ1 expression is closely associated with prognosis, clinicopathological parameters, cancer-related pathways, TMB, MSI, TME, immune cell infiltration, and immune-related genes via TCGA, Oncomine, and CCLE databases. This evidence concerns the gene FOXQ1 and cancer.